Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

What Is Gonorrhea? What Causes Gonorrhea?
Gonorrhea (from Late Latin gonorrhoia where gonos means "seed" and rhoe means "flow") is a sexually transmitted bacterial infection that tends to attack the mucous membranes of the body. It is the second most common sexually transmitted disease in the U.S.; the first being Chlamydia. The bacteria reside in the warm and moist body cavities of both men and women and are highly contagious. Gonorrhea is the most common cause of female infertility and is also known as "the clap" or "the drip". Only a fraction of women infected with the disease show any symptoms, leaving them unaware of their condition. If left untreated, gonorrhea patients can develop pelvic inflammatory disease or PID (women), or an inflammation of the epididymis, prostate gland, or urethral structure (men), all of which are far more difficult to treat.
generic viagra online
What Are Kidney Stones? What Causes Kidney Stones?
Kidney stones, usually comprised of a compound called calcium oxalate, are the result of a build-up of dissolved minerals on the inner lining of the kidneys. These deposits can grow to the size of a golf ball while maintaining a sharp, crystalline structure. They may be small and pass unnoticed out of the urinary tract, but they may also cause extreme pain upon exiting. Kidney stones that remain inside the body can lead to many conditions, including severe pain and ureter (the tube connecting the kidney and bladder) blockage that obstructs the path urine uses to leave the body.
News of the day
European Paediatric Influenza Analysis (EPIA) Group Formed To Quantify The Burden Of Seasonal Influenza In Children In Europe
The Netherlands Institute for Health Services Research (NIVEL) and SDI, a U.S. private-sector healthcare information company, announced the formation of the European Paediatric Influenza Analysis (EPIA) group, created to generate data needed to inform the decision process about paediatric influenza vaccination policy in individual European countries. Researchers from Denmark, England, Finland, Italy, the Netherlands, Scotland, Spain and Wales are participating; it is hoped that other countries will also join. EPIA was formed to address knowledge gaps highlighted in a recent European Centre for Disease Prevention and Control (ECDC) report that concluded that a key barrier to decision-making about paediatric flu vaccines is the lack of high-quality, European-specific data on disease burden, especially for young children. It is estimated by ECDC that at least 40,000 people die each year from influenza in the European Union (EU). EPIA will present the initial results from their research project at the 27th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID) in June.
Health Insurance

Symposium On Synthetic Biology, July 9 -10, 2009

The emerging field of synthetic biology uses engineering techniques to manipulate biological materials, enabling scientists to create new biological systems or even engineer new life forms. Though these technologies could lead to the creation of beneficial materials and applications for human health, they also raise a host of public policy, legal, and ethical questions. A symposium to be held by the U.S. National Academies, the Organization for Economic Cooperation and Development, and the Royal Society on July 9 and 10 will explore the implications of synthetic biology for policymakers, researchers, industry, and the public. SYMPOSIUM DETAILS: 9 a.m. to 5:15 p.m. EDT on July 9 and from 8:30 a.m. to 5:15 p.m. EDT on July 10 in Room 100 of the National Academies" Keck Center, 500 Fifth St., N.W., Washington, D.C. A full agenda can be found at http://sites.nationalacademies.org/pga/stl/PGA_050738 WEBCAST: The following sessions on July 9 will be webcast live (audio) at http://national-academies.org: 9 a.m. -- Welcome: Ralph Cicerone, president, U.S. National Academy of Sciences 9:15 a.m. -- Keynote Address: Arden Bement Jr., director, National Science Foundation 9:45 a.m. -- Panel Discussion: Synthetic Biology Overview 11:15 a.m. -- Panel Discussion: Public Policy -- Government Perspectives and Approaches Sara Frueh National Academy of Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009